Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors.

Basic Information

ID: ALA1136701

Journal: Bioorg Med Chem Lett

Title: Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors.

Authors: Maw GN, Allerton CM, Gbekor E, Million WA.

Abstract: The SAR of a series of beta-carboline derived type 5 phosphodiesterase inhibitors has been explored and we have discovered compounds with excellent levels of PDE5 potency and selectivity over PDE6. However, the series exhibits low levels of selectivity over PDE11, a phosphodiesterase with unknown function.

CiteXplore: 12668004

DOI: 10.1016/s0960-894x(03)00159-8

Patent ID: